Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Nbaa Masood & Joohi Jimenez-Shahed. (2023) Effective Management of “OFF” Episodes in Parkinson’s Disease: Emerging Treatment Strategies and Unmet Clinical Needs. Neuropsychiatric Disease and Treatment 19, pages 247-266.
Read now
Read now
Tanvirul Hye, Sakib M. Moinuddin, Tanoy Sarkar, Trieu Nguyen, Dipongkor Saha & Fakhrul Ahsan. (2023) An evolving perspective on novel modified release drug delivery systems for inhalational therapy. Expert Opinion on Drug Delivery 20:3, pages 335-348.
Read now
Read now
Robert A. Hauser, Peter A. LeWitt & Cynthia L. Comella. (2021) On demand therapy for Parkinson’s disease patients: Opportunities and choices. Postgraduate Medicine 133:7, pages 721-727.
Read now
Read now
Viorelia Adelina Constantin, József Attila Szász, Károly Orbán-Kis, Elena Cecilia Rosca, Maria Popovici, Amalia Cornea, Ligia Ariana Bancu, Marius Ciorba, István Mihály, Előd Nagy, Szabolcs Szatmári & Mihaela Simu. (2020) Levodopa-Carbidopa Intestinal Gel Infusion Therapy Discontinuation: A Ten-Year Retrospective Analysis of 204 Treated Patients. Neuropsychiatric Disease and Treatment 16, pages 1835-1844.
Read now
Read now
József Attila Szász, Viorelia Adelina Constantin, Károly Orbán-Kis, Attila Rácz, Ligia Ariana Bancu, Dan Georgescu, János Szederjesi, István Mihály, Ana-Mária Fárr, Krisztina Kelemen, Tamás Vajda & Szabolcs Szatmári. (2019) Profile Of Patients With Advanced Parkinson’s disease Suitable For Device-Aided Therapies: Restrospective Data Of A Large Cohort Of Romanian Patients. Neuropsychiatric Disease and Treatment 15, pages 3187-3195.
Read now
Read now
Articles from other publishers (12)
Abhinav Ram Mohan, Qiang Wang, Sneha Dhapare, Elizabeth Bielski, Anubhav Kaviratna, Liangfeng Han, Susan Boc & Bryan Newman. (2022) Advancements in the Design and Development of Dry Powder Inhalers and Potential Implications for Generic Development. Pharmaceutics 14:11, pages 2495.
Crossref
Crossref
József Attila Szász, Viorelia Adelina Constantin, Károly Orbán-Kis, Ligia Ariana Bancu, Simona Maria Bataga, Marius Ciorba, Előd Nagy, Mircea Radu Neagoe, István Mihály, Róbert Máté Szász, Krisztina Kelemen, Mihaela Simu & Szabolcs Szatmári. (2022) Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: Observations and Dilemmas after 10 Years of Real-Life Experience. Pharmaceutics 14:6, pages 1115.
Crossref
Crossref
Savvas Dimiou, Rui M. Lopes, Ilona Kubajewska, Ryan D. Mellor, Corinna S. Schlosser, Manjunath S. Shet, Hugh Huang, Ozgur Akcan, Garth T. Whiteside, Andreas G. Schätzlein & Ijeoma F. Uchegbu. (2022) Particulate levodopa nose-to-brain delivery targets dopamine to the brain with no plasma exposure. International Journal of Pharmaceutics 618, pages 121658.
Crossref
Crossref
Yuqing Ye, Ying Ma & Jesse Zhu. (2022) The future of dry powder inhaled therapy: Promising or discouraging for systemic disorders?. International Journal of Pharmaceutics 614, pages 121457.
Crossref
Crossref
Jong‐Min Moon, Hazhir Teymourian, Ernesto De la Paz, Juliane R. Sempionatto, Kuldeep Mahato, Thitaporn Sonsa‐ard, Nickey Huang, Katherine Longardner, Irene Litvan & Joseph Wang. (2021) Non‐Invasive Sweat‐Based Tracking of L‐Dopa Pharmacokinetic Profiles Following an Oral Tablet Administration. Angewandte Chemie International Edition 60:35, pages 19074-19078.
Crossref
Crossref
Jong‐Min Moon, Hazhir Teymourian, Ernesto De la Paz, Juliane R. Sempionatto, Kuldeep Mahato, Thitaporn Sonsa‐ard, Nickey Huang, Katherine Longardner, Irene Litvan & Joseph Wang. (2021) Non‐Invasive Sweat‐Based Tracking of L‐Dopa Pharmacokinetic Profiles Following an Oral Tablet Administration. Angewandte Chemie 133:35, pages 19222-19226.
Crossref
Crossref
József Attila Szász, Viorelia Adelina Constantin, Károly Orbán-Kis, Ligia Ariana Bancu, Marius Ciorba, István Mihály, Előd Ernő Nagy, Róbert Máté Szász, Krisztina Kelemen, Mihaela Adriana Simu & Szabolcs Szatmári. (2021) Management Challenges of Severe, Complex Dyskinesia. Data from a Large Cohort of Patients Treated with Levodopa-Carbidopa Intestinal Gel for Advanced Parkinson’s Disease. Brain Sciences 11:7, pages 826.
Crossref
Crossref
Thoa Duong, Clara López-Iglesias, Piotr K. Szewczyk, Urszula Stachewicz, Joana Barros, Carmen Alvarez-Lorenzo, Mohammad Alnaief & Carlos A. García-González. (2021) A Pathway From Porous Particle Technology Toward Tailoring Aerogels for Pulmonary Drug Administration. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Crossref
Yusuf O. Cakmak, Burak Ozsoy, Sibel Ertan, Ozgur O. Cakmak, Gunes Kiziltan, Hale Yapici-Eser, Ecem Ozyaprak, Selim Olcer, Hakan Urey & Yasemin Gursoy-Ozdemir. (2020) Intrinsic Auricular Muscle Zone Stimulation Improves Walking Parameters of Parkinson's Patients Faster Than Levodopa in the Motion Capture Analysis: A Pilot Study. Frontiers in Neurology 11.
Crossref
Crossref
Ronald F. Pfeiffer, Stuart H. Isaacson & Rajesh Pahwa. (2020) Clinical implications of gastric complications on levodopa treatment in Parkinson's disease. Parkinsonism & Related Disorders 76, pages 63-71.
Crossref
Crossref
Julia Paik. (2020) Levodopa Inhalation Powder: A Review in Parkinson’s Disease. Drugs 80:8, pages 821-828.
Crossref
Crossref
Tomasz R. Sosnowski. 2020. Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications. Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications
327
344
.